Mpho Malima
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
Papers in
-
- Cancer Genomics and Diagnostics 10
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Journals
- Nature (7 papers)Nature Cancer (4 papers)Nature Medicine (3 papers)Nature Communications (2 papers)Nature Genetics (2 papers)
- Partner nations
- United Kingdom
In The Last Decade
Mpho Malima
18 papers receiving 1.8k citations
Mpho Malima's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 543
- Oncology 521
- Pulmonary and Respiratory Medicine 480
- Health, Toxicology and Mutagenesis 171
- Immunology 128
Countries citing papers authored by Mpho Malima
This map shows the geographic impact of Mpho Malima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mpho Malima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mpho Malima more than expected).
Fields of papers citing papers by Mpho Malima
This network shows the impact of papers produced by Mpho Malima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mpho Malima. The network helps show where Mpho Malima may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 546 |
| 2 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 268 |
| 3 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 192 |
| 4 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 159 |
| 5 | Genomic–transcriptomic evolution in lung cancer and metastasis Hit paper breakdown → | 2023 | 140 |
| 6 | 2022 | 93 | |
| 7 | 2023 | 90 | |
| 8 | 2020 | 75 | |
| 9 | 2023 | 72 | |
| 10 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 65 |
| 11 | 2021 | 51 | |
| 12 | 2024 | 29 | |
| 13 | 2024 | 29 | |
| 14 | 2024 | 23 | |
| 15 | 2025 | 5 | |
| 16 | 2025 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2026 | 1 |
About Mpho Malima
Mpho Malima is a scholar working on Cancer Research, Oncology, Immunology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (2 papers), T-cell and B-cell Immunology (2 papers), Epigenetics and DNA Methylation (1 paper), Nutrition and Health in Aging (1 paper), Air Quality and Health Impacts (1 paper) and AI in cancer detection (1 paper). The work is most often cited by research in Cancer Research (543 citations), Oncology (521 citations), Pulmonary and Respiratory Medicine (480 citations), Health, Toxicology and Mutagenesis (171 citations) and Immunology (128 citations). Mpho Malima has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, Nature Cancer, Nature Medicine, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.